Cafepharma Today

January 28 2025 - Versant invests again in obesity, this time backing Helicore Biopharma
Versant invests again in obesity, this time backing Helicore Biopharma
Enhertu, with new FDA OK, set to supplant chemo in HER2-low breast cancer
Takeda regains home rights to phase 3-stage depression drug from Neurocrine
Stopwatch starts on reviews of GSK's long-acting asthma drug
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

ViroPharma adds 2nd drug
Bizjournals.com
Friday, November 28, 2008 - 10:17am
tags:
Analysts: Big Biotech will grow despite economy
Fierce Biotech
Friday, November 28, 2008 - 10:12am
tags:
IMPAX Receives Final FDA Approval for Generic Wellbutrin(R) XL 150 mg
Marketwatch
Friday, November 28, 2008 - 10:11am
tags:
From Patent Thickets to Payoffs: How Big Pharma Fights Generics
WSJ Online
Friday, November 28, 2008 - 9:59am
tags:
Novartis CEO sees higher dividend in future
Trading Markets
Friday, November 28, 2008 - 9:54am
tags:
RegeneRx: A Beaten Down Biotech
Seeking Alpha
Friday, November 28, 2008 - 9:53am
tags:
Enzon biotech sale under threat
In-PharmaTechnologist
Friday, November 28, 2008 - 9:52am
tags:
Lilly withdraws Cymbalta chronic pain application, plans to resubmit request in early 2009
Yahoo/AP
Friday, November 28, 2008 - 9:51am
tags:
Pfizer HIV drug wins FDA approval
Bizjournals.com
Friday, November 28, 2008 - 9:50am
tags:
AstraZeneca says new infant lung drug may face US delay on FDA request for more information
Yahoo/AP
Friday, November 28, 2008 - 9:49am
tags:
Pozen gets second Treximet challenge
Bizjournals.com
Friday, November 28, 2008 - 9:49am
tags:
Johnson & Johnson Is the Latest FDA Casualty
Seeking Alpha
Friday, November 28, 2008 - 9:48am
tags:
Abbott Labs Starting To Slide
Investopedia
Friday, November 28, 2008 - 9:47am
tags:
Drugmaker Delay on Generics Cost EU3 Billion, EU Says
Bloomberg
Friday, November 28, 2008 - 9:44am
tags:
Analyst eyes big buyouts by Pfizer and Merck, with Amgen and Gilead potential targets
Yahoo/AP
Wednesday, November 26, 2008 - 12:20pm
tags:
Clinical Trial Disclosure Is Incomplete: Study
Pharmalot
Wednesday, November 26, 2008 - 9:37am
tags:
Basilea shares plunge on major delay for antibiotic
Fierce Biotech
Wednesday, November 26, 2008 - 9:33am
tags:
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
Yahoo
Wednesday, November 26, 2008 - 9:32am
tags:
Roche Says It'll Still Buy Genentech, Investors Think Otherwise
Seeking Alpha
Wednesday, November 26, 2008 - 9:28am
tags:
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Yahoo
Wednesday, November 26, 2008 - 9:02am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information